跳至主要内容
临床试验/NCT00911001
NCT00911001已完成不适用

Compliance and Treatment Satisfaction in Prophylaxis of Postsurgical Thromboembolism

Bayer0 个研究点目标入组 480 人开始时间: 2008年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Bayer
入组人数
480
主要终点
To measure the Treatment Satisfaction with medication through the self administered scale TSQM.

研究概览

简要总结

Patients that are on total knee/hip replacement initiate prophylaxis treatment on the hospital ground. Once they leave the hospital, as outpatients they continue with the treatment at least during two consecutive weeks. Patients will be instructed to follow treatment recommendations (either LMWH or oral treatment, at physician discretion) and to come back to the surgeon after that period. At that visit, the Treatment Satisfaction Questionaire with Medication (TSQM) test as well as the Moriski-Green Questionaire (measures compliance with medication) will be answer by the patient. TSQM is an self administered validated scale (validated also in spanish) that measures in a generic way the treatment satisfaction to a treatment. Morinski-Green test will be used to measure the compliance degree on medication.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients in antithrombotic prophylaxis treatment after total knee/hip replacement. This is an epidemiological study where the patients to be included will be those that are treated with antithrombotics as out-patients in real life conditions.

排除标准

  • Patients who has been previously treated with injectable antithrombotic treatments.
  • Diabetic patients treated with insulin.
  • Patients who do not sign Informed Consent Form.

结局指标

主要结局

To measure the Treatment Satisfaction with medication through the self administered scale TSQM.

时间窗: 2 weeks

次要结局

  • To measure compliance with medication and the relationship with satisfaction through the Moriski-Green Questionaire(2 weeks)

研究者

发起方
Bayer
申办方类型
Industry
责任方
Sponsor

相似试验